Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 6/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6517071 | 0.91 | ALDH1A1 (0.50) | LMNAKMT2AALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL6524375 | 0.82 | TDP1 (0.44) | LMNAKMT2AMAPTALDH1A1RAB9A | |
| SCHEMBL6520861 | 0.82 | KMT2A (0.43) | LMNAKMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL6524262 | 0.81 | TDP1 (0.44) | LMNAKMT2AALDH1A1L3MBTL1RAB9A | |
| SCHEMBL6518200 | 0.80 | L3MBTL1 (0.49) | LMNAKMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL13748438 | 0.79 | NPC1 (0.62) | LMNAKMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL6523117 | 0.79 | ELANE (0.44) | LMNAKMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL6518882 | 0.79 | KMT2A (0.46) | LMNAKMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL6519565 | 0.78 | KMT2A (0.65) | LMNAKMT2AMAPTALDH1A1MAPK1 | |
| SCHEMBL6514461 | 0.78 | KMT2A (0.65) | LMNAKMT2AMAPTALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | LMNA 2459/4885KMT2A 1067/4885MAPT 3438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.